phenoxybenzamine has been researched along with Exocrine Pancreatic Insufficiency in 1 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Exocrine Pancreatic Insufficiency: A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, RK | 1 |
| Peters, JI | 1 |
| Sirinek, KR | 1 |
| Levine, BA | 1 |
1 review available for phenoxybenzamine and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
von Hippel-Lindau syndrome presenting as pancreatic endocrine insufficiency: a case report.
Topics: Adult; Angiomatosis; Combined Modality Therapy; Exocrine Pancreatic Insufficiency; Female; Humans; P | 1989 |